Status:
COMPLETED
Early Access to ART for All in Swaziland: Effects on Economic Outcomes
Lead Sponsor:
Till Bärnighausen
Collaborating Sponsors:
Clinton Health Access Initiative Inc.
Conditions:
HIV/AIDS
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the impact of offering early antiretroviral therapy to HIV-positive individuals in government-managed health facilities in Swaziland on a range of economic out...
Detailed Description
The MaxART study is a three-year stepped-wedge randomized trial with open enrollment for all adults 18 years and older across 14 rural health facilities in Swaziland's Hhohho Region. The main trial re...
Eligibility Criteria
Inclusion
- All HIV-positive individuals who are aged 18 years or older, are ART naïve and attend the health facilities included in the study
Exclusion
- All HIV-positive individuals who are \<18 years of age
- All HIV-positive pregnant or breastfeeding women
- All HIV-positive individuals who did not consent to participate
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2017
Estimated Enrollment :
3019 Patients enrolled
Trial Details
Trial ID
NCT03789448
Start Date
September 1 2014
End Date
August 31 2017
Last Update
January 4 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.